Michael Jain, MD Assistant Member, Department of Blood and Marrow Transplant and Cellular Immunotherapy, @MoffittNews tells us about the outcomes of the US CAR-T Cell Consortium study investigating bridging therapy prior to delivery of CAR-T cell therapy.
CAR-Natural Killer (NK) Cell Therapy
